Skip to main content

Thanks to a $28 million grant, Harvard is heavily researching artificial intelligence

Some of the most intelligent minds in the country are taking a closer look at artificial intelligence, and if the student surpasses the master in this scenario, the world will have some pretty impressive machines on its hands. The Intelligence Advanced Research Projects Activity (IARPA), a government institution that concerns itself with large-scale research efforts, has awarded a $28 million grant to Harvard’s John A. Paulson School of Engineering and Applied Sciences (SEAS), Harvard’s Center for Brain Science (CBS), and its Department of Molecular and Cellular Biology. The sizable grant to these three departments is meant to help the famed Boston institution develop “advanced machine learning algorithms by pushing the frontiers of neuroscience.”

The goal of the latest research effort is to better understand the human brain so that machines may emulate our biological capabilities. Today, our minds and our machines each excel at two differing functions — while humans are able to quickly recognize patterns and learn, machines are far better at processing large amounts of data. The sweet spot, then, would be to design an AI that can not only learn as well as humans can, but do so with the speed of a robot.

Recommended Videos

“This is a moonshot challenge, akin to the Human Genome Project in scope,” said project leader David Cox, assistant professor of molecular and cellular biology and computer science. “The scientific value of recording the activity of so many neurons and mapping their connections alone is enormous, but that is only the first half of the project,” Cox continued. “As we figure out the fundamental principles governing how the brain learns, it’s not hard to imagine that we’ll eventually be able to design computer systems that can match, or even outperform, humans.”

Please enable Javascript to view this content

Of course, if the project proves to be too successful,  the Harvard researchers conducting it could turn out to be the last people on earth who are gainfully employed.

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Faraday Future could unveil lowest-priced EV yet at CES 2025
Faraday Future FF 91

Given existing tariffs and what’s in store from the Trump administration, you’d be forgiven for thinking the global race toward lower electric vehicle (EV) prices will not reach U.S. shores in 2025.

After all, Chinese manufacturers, who sell the least expensive EVs globally, have shelved plans to enter the U.S. market after 100% tariffs were imposed on China-made EVs in September.

Read more
What to expect at CES 2025: drone-launching vans, mondo TVs, AI everywhere
CES 2018 Show Floor

With 2024 behind us, all eyes in tech turn to Las Vegas, where tech monoliths and scrappy startups alike are suiting up to give us a glimpse of the future. What tech trends will set the world afire in 2025? While we won’t know all the details until we hit the carpets of the Las Vegas Convention Center, our team of reporters and editors have had an ear to the ground for months. And we have a pretty good idea what’s headed your way.

Here’s a sneak peek at all the gizmos, vehicles, technologies, and spectacles we expect to light up Las Vegas next week.
Computing

Read more
These unique smart glasses skirt hype and solve a real medical problem
Front view of the SolidddVision smartglasses.

Smart glasses are increasingly being pushed as the future of personal computing. But so far, an overwhelming majority have focused on aspects like social media sharing, pulling up AI agents, or media consumption. Soliddd wants to push smart glasses into a challenging niche of medical science.

At CES 2025, the New York City-based company introduced SolidddVision smart glasses. Soliddd claims these are “the first true vision correction for people living with vision loss due to macular degeneration.” Notably, these glasses won’t require any FDA clearance and will enter the market later this year.

Read more